Antitumor, Analgesic, and Anti-inflammatory Activities of Synthesized Pyrazolines

Thermal electron-transfer-induced oxidation of 2-pyrazolines

Various 3,5-diaryl-1-phenyl-2-pyrazolines were synthesized, and their thermal oxidation to their corresponding 2-pyrazoles was investigated using tetrabutylammonium peroxydisulfate in acetonitrile solution. Compared to the reported oxidative methods, this oxidizing agent provides a clean and non-expensive oxidative reaction in a short reaction time. Based on the proposed reaction mechanism, the extent of co-planarity of the C₃-aryl ring toward C₃=N₂ double bond of the heterocyclic ring affects the electron-donating ability of the heterocyclic ring and decreases the time of oxidative reaction. The experimental results are supported by cyclic voltammetric measurements.

Regioselective Synthesis of Some Pyrazole Scaffolds Attached to Benzothiazole and Benzimidazole Moieties

Condensation of 2-(benzothiazol-2-yl)acetonitrile (1) or 2-(1-methyl-1H-benzimidazol-2-yl)acetonitrile (2) with thiophene-2-carbaldehyde afforded the corresponding acrylonitrile derivatives3or4, respectively. The 1,3-dipolar cycloaddition reaction of the acrylonitrile3or4with nitrile-imine6gave novel pyrazole derivatives pendant to benzothiazole and benzimidazole. The pyrazoline derivative7was converted into the corresponding pyrazole derivative11via thermal elimination of hydrogen cyanide upon heating in sodium ethoxide solution. The structures of the synthesized products were confirmed by IR,1H NMR, and mass spectral techniques.

In vitro and in vivo evaluation of novel anticancer agents in triple negative breast cancer models

Triple negative breast cancer (TNBC) is subtype of breast disease devoid of the estrogen, progesterone, and Her2/neu receptors which are targets for pharmacological intervention. There is a need for novel anti-breast cancer agents that target TNBC. Therefore, novel isochalcone DJ52 was evaluated using the alamar blue dye exclusion assay, the luciferase colony assay, and xenograft models to determine its efficacy and potency. DJ52 significantly decreased proliferation of cells measured by using the alamar blue dye method and produced IC50 values of DJ52, DJ56, and DJ82 at 10-6M, 10-5M, and 10-5M, respectively. In vivo studies were conducted by injecting MDA-MB-231 cells into SCID mice to determine tumor regression was measured over 20 days. DJ52 at 50 mg/kg caused significant decrease in tumor volume (p value <.05) by nearly 50% compared with the control with vehicle alone. These data suggest that DJ52 has merit for further evaluation as a novel anticancer agent.